Correction to: N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ ATM pathway.
Publication
, Journal Article
Yin, Y; Xu, L; Chang, Y; Zeng, T; Chen, X; Wang, A; Groth, J; Foo, W-C; Liang, C; Hu, H; Huang, J
Published in: Mol Cancer
June 19, 2019
Following publication of the original article [1], the authors reported that name that appeared in published online version is incorrect. Aifeng Wang should be Aifen Wang. Corrected name is provided in the author group section above.
Duke Scholars
Published In
Mol Cancer
DOI
EISSN
1476-4598
Publication Date
June 19, 2019
Volume
18
Issue
1
Start / End Page
107
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Yin, Y., Xu, L., Chang, Y., Zeng, T., Chen, X., Wang, A., … Huang, J. (2019). Correction to: N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ ATM pathway. Mol Cancer, 18(1), 107. https://doi.org/10.1186/s12943-019-1034-y
Yin, Yu, Lingfan Xu, Yan Chang, Tao Zeng, Xufeng Chen, Aifen Wang, Jeff Groth, et al. “Correction to: N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ ATM pathway.” Mol Cancer 18, no. 1 (June 19, 2019): 107. https://doi.org/10.1186/s12943-019-1034-y.
Yin Y, Xu L, Chang Y, Zeng T, Chen X, Wang A, et al. Correction to: N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ ATM pathway. Mol Cancer. 2019 Jun 19;18(1):107.
Yin, Yu, et al. “Correction to: N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ ATM pathway.” Mol Cancer, vol. 18, no. 1, June 2019, p. 107. Pubmed, doi:10.1186/s12943-019-1034-y.
Yin Y, Xu L, Chang Y, Zeng T, Chen X, Wang A, Groth J, Foo W-C, Liang C, Hu H, Huang J. Correction to: N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ ATM pathway. Mol Cancer. 2019 Jun 19;18(1):107.
Published In
Mol Cancer
DOI
EISSN
1476-4598
Publication Date
June 19, 2019
Volume
18
Issue
1
Start / End Page
107
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis